论文信息 - VASCULAR LOCALIZATION OF THE 11β‐HYDROXYSTEROID DEHYDROGENASE TYPE II ENZYME - 字舞流文

VASCULAR LOCALIZATION OF THE 11β‐HYDROXYSTEROID DEHYDROGENASE TYPE II ENZYME

1. The enzyme 11β‐hydroxysteroid dehydrogenase type II (11βHSD2) confers specificity on the non‐specific mineralocorticoid receptor by converting cortisol to cortisone.

P. Little | Z. Krozowski | Robin E. Smith | A. Stein-Oakley | J. Maguire

[1] M. Ullian,et al. Corticosterone metabolism and effects on angiotensin II receptors in vascular smooth muscle. , 1995, Circulation research.

[2] T. Mune,et al. Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase , 1995, Nature Genetics.

[3] J. Funder,et al. Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors. , 1989, Endocrinology.

[4] C. Edwards,et al. Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. , 1988, Lancet.

[5] J. Funder,et al. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. , 1988, Science.

[6] J. Funder,et al. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. , 1983, Proceedings of the National Academy of Sciences of the United States of America.